Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb:74:103234.
doi: 10.1016/j.amsu.2021.103234. Epub 2022 Jan 11.

A cross-sectional study of gastrointestinal manifestations in COVID-19 Egyptian patients

Affiliations

A cross-sectional study of gastrointestinal manifestations in COVID-19 Egyptian patients

Ahmed Abozaid Ahmed Teima et al. Ann Med Surg (Lond). 2022 Feb.

Abstract

Background: The latest novel corona virus disease (COVID-19) pandemic shows a significant health concern. We aimed to study the prevalence of gastrointestinal symptoms among COVID-19 Egyptian patients.

Methods: A cross-sectional study was carried out on 860 patients with COVID-19 infection classified according to Ministry of Health Program (MOHP) into three groups (280 patients with mild infection, 258 patients with moderate disease and 322 patients with severe disease). All patients were subjected to medical history, clinical examination, laboratory investigations, high-resolution computed tomography chest (HRCT chest) and other investigations when needed in some patients e.g., upper gastro-intestinal (GI) endoscopy, abdomino-pelvic ultrasound and ECHO.

Results: Gastro-intestinal symptoms were present in 27.2% of the studied patients. The most common reported GIT symptoms were vomiting, diarrhea, abdominal/gastric pain, followed by nausea. GIT symptoms presence was significantly higher in severe cases in comparison to mild or moderate cases. C-reactive protein (CRP), serum ferritin, Aspartate aminotransferase (AST), bilirubin, and creatinine were significantly associated with the presence of GI symptoms.

Conclusions: GI symptoms are prevalent among COVID-19 patients, the most common were vomiting and diarrhea and were associated with COVID-19 severity.

Keywords: ACE2, angiotensin convertory enzyme 2; ALT, alanine aminotransferase; AST, Aspartate aminotransferase; CO-RAD, COVID-19 Reporting and Data System; COVID-19; COVID-19, Corona virus disease; CRP, C-reactive protein; Fecal-oral viral transmission; GI, Gastrointestinal; GIT manifestations in COVID-19; HRCT chest, high-resolution computed tomography chest; IL, interleukin; LDH, Lactate Dehydrogenase; MOHP, Ministry of Health Program; PCR, Polymearase chain reaction; Pandemic; TNF, tumor necrosis factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Distribution of the studied participants regarding COVID-19 severity and GIT symptoms.

References

    1. Gorbalenya A.E., Baker S.C., Baric R.S., et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. Backer J.A., Klinkenberg D., Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25:2000062. doi: 10.2807/1560-7917.ES.2020.25.5.2000062. - DOI - PMC - PubMed
    1. Wu D., Wu T., Liu Q., Yang Z.J. The SARS-CoV-2 outbreak: what we know. Int. J. Infect. Dis. 2020;94:44–48. doi: 10.1016/j.ijid.2020.03.004. - DOI - PMC - PubMed
    1. Kampf G., Todt D., Pfaender S., Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 2020;104:246–251. doi: 10.1016/j.jhin.2020.01.022. - DOI - PMC - PubMed
    1. Kim J.Y., Choe P.G., Oh Y., et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J. Kor. Med. Sci. 2020;35:e61. doi: 10.3346/jkms.2020.35.e6. - DOI - PMC - PubMed